Internal Medicine · 1999 · 21 citations · 10 references
MedicineImmunologyPathologyClinical ImmunologyImmunopathologyPulmonologyPulmonary InfectionsPulmonary InflammationPulmonary PathologyRespiratory DiseaseRespiratory InfectionsRespiratory PathologyAnti-myeloperoxidase AntibodiesAnti-neutrophil Cytoplasmic AntibodiesAnti-neutrophil Cytoplasmic Antibody TestingAntineutrophil AntibodiesAntineutrophil Cytoplasmic AntibodiesChronic Airway InfectionPulmonary Immunopathology
A 56-year-old woman was hospitalized for recurrent hemoptysis. She had been suffering from bronchiectasis for 4 years. Pseudomonas aeruginosa was persistently detected in her sputum. Serum was positive for Myeloperoxidase antineutrophil cytoplasmic antibody (MPO-ANCA) and bactericidal/permeability-increasing protein antineutrophil cytoplasmic antibody (BPI-ANCA). She underwent lung resection. Histopathologically, the resected lung showed bronchiectasis with pulmonary fibrosis but did not show vasculitis. Her serum became negative for the ANCAs after the operation. To date, she has no recurrence of hemoptysis. We discuss this case of bronchiectasis with MPO-ANCA and BPI-ANCA and suggest a possible role for ANCAs in chronic airway infection.
10
Ronald J. Falk, J. Charles Jennette · New England Journal of Medicine · 1988 · 1.4K citations
Medicine, Immunology, Pathology +17
Bactericidal/permeability-increasing protein has endotoxin-neutralizing activity.
M N Marra, C G Wilde, J E Griffith et al. · The Journal of Immunology · 1990 · 276 citations
Autoantibodies against bactericidal/permeability-increasing protein in patients with cystic fibrosis
Minghui Zhao, David Jayne, Leopoldo Ardiles et al. · QJM · 1996 · 118 citations · Full text
Life Sciences, Immunology, Pathology +17